Xcell Biosciences
Business Services · California, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
455 Mission Bay Blvd S, San Francisco, C...Phone Number
(415) 937-0321Website
www.xcellbio.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
2
1
1
1
1
About Xcell Biosciences
Xcellbio is a venture-backed company driven by its mission to enhance the performance and safety of cell and gene-based therapies through the design and development of revolutionary technology platforms. The company's commercial instruments and AI-driven software allow researchers to discover novel insights into immune and tumor biology and enable the translation of these insights at patient scale through the development of its pioneering cell therapy manufacturing platform.Explore more
Xcell Biosciences Org Chart
TS
Mechanical Engineer
MM
Senior Mechanical Engineer
RX
Senior Software Engineer
GH
Engineering Technician
EM
Senior Scientist
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Xcell Biosciences your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on Xcell Biosciences recently announced quarterly report
Check if Xcell Biosciences has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Check out if Xcell Biosciences is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at Xcell Biosciences
Click to see if Xcell Biosciences had a recent Job posting/layoffs
Xcell Biosciences, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when Xcell Biosciences launches new products
Funding: Get notified immidiatlly once Xcell Biosciences has new funding data
Recommended Actions
Reach out to Masked Content who joined Xcell Biosciences as Masked Content
Find 2 more new buyers
Compare Similar Companies to Xcell Biosciences
Compare insights from companies similar to Xcell Biosciences, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Xcell Biosciences is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Xcell Biosciences is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Xcell Biosciences.
Xcell Biosciences financials insights
Gather financial insights about Xcell Biosciences, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2017
Series A
$12M
2021
Debt
$240K
2022
Series B
$27.5M
Xcell Biosciences Tech Stack
A closer look at the technologies used by Xcell Biosciences
Most Recent Scoops
Facilities Relocation / Expansion
Xcell Biosciences is planning to move offices in January 2026. The move will impact approximately 18 employees at the existing office located at 455 Mission Bay Boulevard South, San Francisco, CA.
Facilities Relocation/Expansion
Event
Product Marketing, Events, Business Intelligence, Engineering, Analytics & Insights, Research & Development, Sales, Search, Software, Bioengineering, Laboratory Operations, Clinical Operations, Field Marketing, Operations
Person-Based
Person-Based
Open Position
Xcell Biosciences News & Media
Xcell Biosciences Announces Joint Research Collaboration with Thermo Fisher Scientific to Advance the Next Generation of Cell Therapies
SAN FRANCISCO--(BUSINESS WIRE)--Xcell Biosciences (Xcellbio), a San Francisco-based instrumentation company focused on cell and gene therapy applications, today announced a strategic collaboration with Thermo Fisher Scientific Inc., the world leader in serving science, to advance research in regulatory T cells (Tregs) and tumor-infiltrating lymphocytes (TILs). While significant progress has been made in the cell therapy space leveraging Chimeric Antigen Receptor T (CAR T) cells, this collaboratXcellbio Announces Commercial Licensing & Supply Agreement to Support Commercial Production of Gene Therapy for Sickle Cell disease
SAN FRANCISCO--(BUSINESS WIRE)--Xcellbio announced today that it had granted bluebird bio, Inc., a commercial license and entered into a supply agreement for the use of Xcellbio’s proprietary cell manufacturing technology, AVATAR™, to support commercialization of LYFGENIA® gene therapy for the treatment of sickle cell disease for the treatment of patients 12 years of age or older with sickle cell disease and a history of vaso-occlusive events. Xcellbio’s proprietary technology platform, AVATAR™Xcell Biosciences and Royal Perth Hospital to Develop Next Gen Automated TIL Manufacturing Workflow
MELBOURNE, Australia & PERTH, Australia--(BUSINESS WIRE)--Xcell Biosciences Australia PTY LTD (Xcellbio), an affiliate of Xcell Biosciences, Inc., a platform company focused on cell and gene therapy applications, and Royal Perth Hospital announced a collaboration aimed at developing an automated, clinical-scale manufacturing workflow for therapies based on tumor-infiltrating lymphocytes (TILs) using the AVATAR™ Foundry system. Ultimately, the goal is to empower Royal Perth Hospital physicians aXcellbio Announces Partnership with Planet Innovation to Develop and Manufacture Next Generation Instruments to Improve potency for Rapid Cell Therapy Manufacturing
MELBOURNE, Australia--(BUSINESS WIRE)--Xcell Biosciences Australia Pty Ltd (Xcellbio), an Australian affiliate of the San Francisco-based instrumentation company focused on cell and gene therapy applications, has announced that it has entered into an agreement with the Royal Perth Hospital to use its AVATAR™ Foundry platform in a clinical trial focused on rapid manufacturing of more potent cancer-killing cell therapies. Planet Innovation, an Australian headquartered medtech innovation company,
Read more news
Top Business Services Companies
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Xcell Biosciences
Sign Up For FreeTo access detailed company insights
Xcellbio is a venture-backed company driven by its mission to enhance the performance and safety of cell and gene-based therapies through the design and development of revolutionary technology platforms. The company's commercial instruments and AI-driven software allow researchers to discover novel insights into immune and tumor biology and enable... Read More
